1 Followers on Owler
OverviewCompetitorsNews & Insights

Novonco Competitors or Alternatives

Novonco's top competitors include NexImmune, bluebird bio and Aura.

Unlock 10 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Novonco's company profile

Jack Kavanaugh

Interim-CEO

70/100
25 - 100
$0
$100K - 5M
  • $0
    $100K - 5M
  • 25 - 100
    $0
  • $100K - 5M
  • 70/100
  • 25 - 100
  • $0
  • $100K - 5M
View ProfileView
1
Novonco's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
2
Novonco's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
248
$821.4M
$103.9M
  • $821.4M
    $103.9M
  • 248
    $821.4M
  • $103.9M
  • 73/100
  • 248
  • $821.4M
  • $103.9M
View ProfileView
3
Novonco's Competitor - Aura logo

Natalie Holles

President & CEO

- -
50
$751.4M
  • $751.4M
  • 50
    $751.4M
  • - -
  • 50
  • $751.4M
View ProfileView
4
Novonco's Competitor - Centrose logo

James R. Prudent

President & CEO

90/100
1 - 25
$4.7M
$5M - 25M
  • $4.7M
    $5M - 25M
  • 1 - 25
    $4.7M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $4.7M
  • $5M - 25M
View ProfileView
5
Novonco's Competitor - BiomaRx logo

Zeid Barakat

Co-Founder & CEO

67/100
25 - 100
- -
$100K - 5M
  • - -
    $100K - 5M
  • 25 - 100
    - -
  • $100K - 5M
  • 67/100
  • 25 - 100
  • - -
  • $100K - 5M
View ProfileView
Novonco's top 13 competitors are NexImmune, bluebird bio, Aura, Juno Therapeutics, Centrose, BiomaRx, Amgen, Novartis, Perthera, MabVax, Jounce, CR Pharmaceutical and Immunomedics. Together they have raised over 18.9B between their estimated 189.8K employees. Novonco's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 11B. Novonco has 35 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 13,556.

Novonco VS NexImmune

NexImmune is one of Novonco's top rivals. NexImmune was founded in Gaithersburg, Maryland} in 2011. Like Novonco, NexImmune also competes in the Biotechnology space. Compared to Novonco, NexImmune generates $ less revenue.

Novonco VS bluebird bio

bluebird bio is Novonco's #2 competitor. bluebird bio was founded in 1992, and is headquartered in Somerville, Massachusetts. Like Novonco, bluebird bio also operates in the Biotechnology space. bluebird bio generates $101.9M more revenue vs. Novonco.

Novonco VS Aura

Aura is a top competitor of Novonco. Aura's headquarters is in Boston, Massachusetts, and was founded in 2009. Like Novonco, Aura also works within the Biotechnology sector. Aura generates NaN% of Novonco's revenue.

Looking for similar companies to Novonco?

Similar Companies

Pharmaceuticals companies in Los Angeles

See 82 companies 
Pharmaceuticals companies in Los Angeles Metropolitan Area

See 491 companies 
Pharmaceuticals & Biotechnology companies in Los Angeles

See 198 companies 
Biotechnology companies in Los Angeles

See 136 companies 
Biotechnology companies in Los Angeles Metropolitan Area

See 672 companies 
Pharmaceuticals & Biotechnology companies in Los Angeles Metropolitan Area

See 1,052 companies 
Pharmaceuticals companies in California

See 1,452 companies 
Pharmaceuticals companies with revenue in $100K-5.0M range

See 2,189 companies 
Pharmaceuticals companies with employees in 25-100 range

See 2,849 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Novonco and Novonco's Competitors

October 15, 2026Cameronjournal
NEW YORK , Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Novartis AG ("Novartis" or the "Company") (NYS...
Today 6:39 AMAd-hoc-news
Valuation and range The 52-week range was EUR 247.65 to EUR 392.85 on October 15, 2026. Amgen stock traded at EUR 386.78 at 8:04 a.m. CEST on October 1...
October 15, 2026Pharmabiz
Pfizer Inc. will present data from more than 50 company─sponsored, investigator─sponsored and collaborative research abstracts across its infectious di...
October 15, 2026Quartz
Vir Biotechnology will receive $90 million upfront and could earn up to $1.74 billion in later milestone payments...
October 14, 2026Pharmabiz
Merck, known as MSD outside of the United States and Canada, announced that first─time results from three pivotal clinical trials will be presented dur...
October 15, 2026RTTNews
Lilly (LLY) reported that 27.7% of Omvoh-treated ulcerative colitis patients achieved comprehensive disease control at one year, versus 14% on placebo....
October 15, 2026Investing
Amgen Inc Follow Analyze AMGN Included in our AI-picked strategies · Review strategies 426.11 ▲ +13.27 (+3.21%) Closed 430.85 ▲ +4.74 (+1.11%) After Ho...
October 15, 2026Benzinga
Pfizer Inc (NYSE:PFE) shares are climbing Thursday to a new 52-week high as drugmakers rally broadly. The move comes a week after the FDA approved a Tu...
October 14, 2026Tradingview
The ClearBridge Appreciation Strategy outperformed its S&P 500 benchmark during the third quarter. On an absolute basis, the strategy had positive cont...
October 15, 2026Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2026 financial results an...

Frequently Asked Questions about Novonco

  1. Who are Novonco's top competitors?

    Novonco's top 3 competitors are NexImmune, bluebird bio, Aura.

  2. Who is similar to Novonco?

    NexImmune is the most similar to Novonco. bluebird bio and Aura are also similar to Novonco.

  1. Are Novonco and NexImmune competitors?

    Yes, NexImmune is one of Novonco’s top competitors.